JPH02212431A - Tampon for improving metrorrhagia and leukorrhea - Google Patents
Tampon for improving metrorrhagia and leukorrheaInfo
- Publication number
- JPH02212431A JPH02212431A JP1032478A JP3247889A JPH02212431A JP H02212431 A JPH02212431 A JP H02212431A JP 1032478 A JP1032478 A JP 1032478A JP 3247889 A JP3247889 A JP 3247889A JP H02212431 A JPH02212431 A JP H02212431A
- Authority
- JP
- Japan
- Prior art keywords
- tampon
- drug
- improving
- radix
- leucorrhoea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010046901 vaginal discharge Diseases 0.000 title abstract description 7
- 206010027514 Metrorrhagia Diseases 0.000 title abstract 2
- 201000005630 leukorrhea Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 208000037853 Abnormal uterine bleeding Diseases 0.000 claims description 22
- 230000000694 effects Effects 0.000 abstract description 6
- 229920000742 Cotton Polymers 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract description 2
- 244000299461 Theobroma cacao Species 0.000 abstract description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 abstract description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 abstract description 2
- 235000001046 cacaotero Nutrition 0.000 abstract description 2
- 229960003511 macrogol Drugs 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 239000003381 stabilizer Substances 0.000 abstract description 2
- 229940099259 vaseline Drugs 0.000 abstract description 2
- 241000180649 Panax notoginseng Species 0.000 abstract 2
- 235000003143 Panax notoginseng Nutrition 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 7
- 206010046798 Uterine leiomyoma Diseases 0.000 description 5
- 210000003756 cervix mucus Anatomy 0.000 description 5
- 201000010260 leiomyoma Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241001106477 Paeoniaceae Species 0.000 description 3
- 206010033645 Pancreatitis Diseases 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 241001530105 Anax Species 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 241001072256 Boraginaceae Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001071917 Lithospermum Species 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000004696 endometrium Anatomy 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000025421 tumor of uterus Diseases 0.000 description 2
- 206010046766 uterine cancer Diseases 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004272 Benign hydatidiform mole Diseases 0.000 description 1
- 241000255783 Bombycidae Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010008260 Cervical discharge Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001317370 Euchroma Species 0.000 description 1
- 208000006937 Hydatidiform mole Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000036216 Placenta Previa Diseases 0.000 description 1
- 206010035142 Placental polyp Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 208000003142 Retained Placenta Diseases 0.000 description 1
- 206010038758 Retained placenta or membranes Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010056738 Uterine cervical laceration Diseases 0.000 description 1
- 206010046820 Uterine rupture Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000006673 abdominal tuberculosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 210000002451 diencephalon Anatomy 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000016018 endometrial polyp Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 201000007116 gestational trophoblastic neoplasm Diseases 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 201000009825 uterine corpus cancer Diseases 0.000 description 1
- 206010046811 uterine polyp Diseases 0.000 description 1
- 208000037965 uterine sarcoma Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
- A61F13/202—Catamenial tampons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
- A61F2013/8408—Additives, e.g. for odour, disinfectant or pH control with odour control
- A61F2013/8435—Additives, e.g. for odour, disinfectant or pH control with odour control with plant derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
- A61F2013/8455—Additives, e.g. for odour, disinfectant or pH control being lubricants
- A61F2013/8458—Additives, e.g. for odour, disinfectant or pH control being lubricants having bees-wax
Landscapes
- Absorbent Articles And Supports Therefor (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
この発明は不正子宮出血及び帯下改善用タンポンに関し
、その目的は不正子宮出血及び帯下による血液等の分泌
物を吸収するとともに、副作用がなく速効性及び持続性
の抗腫瘍、抗炎症作用を有する不正子宮出血及び帯下改
善用タンポンの提供にある。Detailed Description of the Invention (Field of Industrial Application) This invention relates to a tampon for improving abnormal uterine bleeding and leucorrhoea. The purpose of the present invention is to provide a tampon for improving abnormal uterine bleeding and leucorrhoea, which has fast-acting and long-lasting antitumor and anti-inflammatory effects.
(発明の背景)
婦人の不正子宮出血の主因としては以下のものが挙げら
れる。(Background of the Invention) The following are the main causes of abnormal uterine bleeding in women.
■ 間脳、下垂体、卵巣系等の機能異常によるもので、
過多月経、頻発月経も含まれ、他に卵巣の内分泌活性腫
瘍(顆粒膜細胞種、莢膜細胞種)によるものもある。■ It is caused by functional abnormalities of the diencephalon, pituitary gland, ovarian system, etc.
This includes menorrhagia and frequent menstruation, and may also be due to endocrine active tumors of the ovary (granulosa cell type, capsular cell type).
■ 子宮腫瘍によるもので、子宮体部、子宮頚部、腹部
の平滑筋から発生する紫膜下筋腫、間質性筋腫、粘膜上
筋腫等の良性腫瘍、子宮頚癌、子宮体癌等の悪性腫瘍、
絨毛上皮腫、子宮肉腫等がある。■ Caused by uterine tumors, including benign tumors such as subpurpuric fibroids, interstitial fibroids, and supramucous fibroids that arise from the smooth muscles of the uterine body, cervix, and abdomen, as well as malignant tumors such as cervical cancer and uterine corpus cancer. ,
These include chorioepitheloma and uterine sarcoma.
■ 炎症によるもので、子宮内膵炎、子宮腹部結核等が
ある。■ Caused by inflammation, including intrauterine pancreatitis and uterine abdominal tuberculosis.
■ 子宮内膜ポリープ、頚管ポリープ、子宮腹部康爛、
子宮内異物等によるものがある。■ Endometrial polyps, cervical polyps, uterine abdominal erosions,
It may be caused by a foreign body in the uterus.
■ 出血性素因によるもので、白血病、血小板減少症等
の血液疾患による異常出血がある。■ This is due to a bleeding diathesis, including abnormal bleeding due to blood diseases such as leukemia and thrombocytopenia.
■ 妊娠、分娩、産褥に関するもので、妊娠初期に於い
ては、流産、子宮外妊娠、胞状奇胎、妊娠後期及び分娩
時に於いては、早産、前置胎盤、常位胎盤早期剥離、子
宮破裂、頚管裂傷、弛緩出血、胎盤遣残、胎盤ポリープ
等がある。■ Regarding pregnancy, delivery, and puerperium, in the early stages of pregnancy, miscarriage, ectopic pregnancy, hydatidiform mole, and in the late pregnancy and at the time of delivery, premature birth, placenta previa, placental abruption, and uterine rupture. , cervical laceration, atonic bleeding, retained placenta, placental polyps, etc.
また、帯下の主因としては、膣帯下は膣炎で、頚管帯下
(頚腹部仮性慶爛の原因となる)は頸管カタルで起こる
のが普通であり、膣、頚管又は子宮体等に発生した腫瘍
から分泌される場合もある。In addition, the main causes of vaginal discharge are vaginitis, and cervical discharge (which causes cervicoabdominal pseudoerythrosis) is usually caused by cervical catarrh; It may also be secreted from tumors that develop in other areas.
(従来の技術)
従来、不正子宮出血又は帯下が認められた患者に対して
は、その原因を検索すべく子宮内膜の試験掻爬による組
織診、子宮造影術、子宮鏡、基礎体温測定、血液検査等
を行なった後に、手術或いは薬剤の投与等の適切な処置
を選択していた。(Prior art) Conventionally, in order to search for the cause of abnormal uterine bleeding or leucorrhoea, patients have been treated with histological examination by test scraping of the endometrium, hysterography, hysteroscopy, basal body temperature measurement, After conducting blood tests, etc., appropriate treatment such as surgery or administration of drugs was selected.
例えば子宮筋腫の場合は、手術的に腫瘍を切除するか、
手術不能の人には放射線療法によって治療し、また男性
ホルモン療法を行なって腫瘍を縮小させていた。For example, in the case of uterine fibroids, the tumor may be surgically removed, or
Those who were inoperable were treated with radiation therapy and androgen therapy to shrink the tumor.
(発明が解決しようとする課題)
しかしながら、不正子宮出血又は帯下が認められてから
適切な処置が施されるまでにはかなりの日数を要し、そ
れまでの間は生理用品を代用して不正子宮出血による血
液等を吸収させて止血を行なうのみであり、症状が更に
悪化することもあった。(Problem to be solved by the invention) However, it takes a considerable number of days after abnormal uterine bleeding or leucorrhoea is recognized until appropriate treatment is taken, and until then, sanitary products are used instead. The only way to stop the bleeding was to absorb blood caused by abnormal uterine bleeding, which sometimes made symptoms even worse.
また、手術的療法による場合は腹部に手術の跡が残ると
ともに輸血による拒絶反応等の問題があり、薬剤では治
癒が不可能な患者に対してのみ限定して行なわれていた
。In addition, surgical therapy leaves surgical scars on the abdomen and causes problems such as rejection due to blood transfusions, so it has been limited to patients who cannot be cured with drugs.
更に、薬剤のみによる治療を行なう場合には、−射的に
長期間の投与が行なわれる為、治癒するまでにかなりの
日数を要した。Furthermore, when treating with only drugs, it takes a considerable number of days for the patient to be cured because the patient is administered for a long period of time.
特にペニシリン等の化学療法剤を内服した場合には、腸
内での菌交代症により体調を崩す等の副作用が生じる恐
れがあった。In particular, when chemotherapeutic agents such as penicillin are taken orally, there is a risk that side effects such as worsening of physical condition may occur due to bacterial replacement in the intestines.
以上のような実情に鑑み業界では不正子宮出血及び帯下
による血液等の分泌物を吸収するとともに、副作用がな
く速効性及び持続性の抗腫瘍、抗炎症作用を有する不正
子宮出血及び帯下改善用タンポンの創出が望まれていた
。In view of the above-mentioned circumstances, the industry is developing products that absorb blood and other secretions caused by abnormal uterine bleeding and leucorrhoea, as well as improving abnormal uterine bleeding and leucorrhoea, which have fast-acting and long-lasting anti-tumor and anti-inflammatory effects without side effects. There was a desire to create a tampon for use.
(課題を解決するための手段)
この発明に係る不正子宮出血及び帯下改善用タンポンは
紫根、当帰、三七を含有する薬剤が含侵又は塗布されて
なることを特徴とする不正子宮出血及び帯下改善用タン
ポンであるから上記課題を悉く解決する。(Means for Solving the Problems) The tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention is characterized by being impregnated with or coated with a drug containing Shikon, Toki, and Sanshichi. Since it is a tampon for improving leucorrhoea, it solves all of the above problems.
以下この発明に係る不正子宮出血及び帯下改善用タンポ
ンの構成を詳細に説明する。The structure of the tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention will be explained in detail below.
(発明の構成)
この発明に於いて、紫根、当帰、三七が好適に使用され
る。(Structure of the Invention) In this invention, Shikon, Toki, and Sanshichi are preferably used.
紫根とは、硬紫根であるムラサキ科Boragina−
ceaeムラサキLithospermum eryt
hrorhizon 5ie−bold et Zu
ccarini (Lithostrermum of
ficinaLeLinne var、 erythr
orhizo?LMaximowicz)の根、及び軟
紫根であルムラサキ科BoraginaceaeのMa
croto−mia euchroma pB11
3 (Lithospltrmua euchro
tga )ioy−1e )の根を指す。Shikon is a hard purple root belonging to the family Boraginaceae.
ceae purple Lithospermum eryt
hrorhizon 5ie-bold et Zu
ccarini (Lithostrermum of
ficinaLeLinne var, erythr
Orhizo? L Maximowicz) roots, and soft purple roots of Ma of the Boraginaceae family.
croto-mia euchroma pB11
3 (Lithospltrmua euchro
tga ) ioy-1e ) root.
この発明に於いて紫根を使用する理由は、紫根の主成分
であるアセチルシコニン及びその加水分解物であるシコ
ニンに抗腫瘍、抗炎症作用、肉芽増殖促進作用等がある
為、不正子宮出血の原因である子宮腫瘍、子宮内膵炎を
治癒する働きがあるからである。The reason why purple root is used in this invention is that acetylshikonin, the main component of purple root, and shikonin, its hydrolyzate, have antitumor, anti-inflammatory, and granulation growth promoting effects, which can cause abnormal uterine bleeding. This is because it has the ability to cure uterine tumors and intrauterine pancreatitis.
また、当帰とは、セリ科Umbelliferae ト
ウキ(大深当帰、大和当帰) AngeLic、a
acutiloba l(ilaga−wa1ホッカイ
トウキ(北海当帰) AnlleLica QCut
i−1oba Kitagawa var、 5utt
iyaaae Flikino %カラトウキAnge
lica 5tnensis (01iver) Di
els及びオニノダケAn11eLica gigas
NakBiの根を指す。In addition, AngeLic, AngeLic, a
acutilobal (ilaga-wa1 Hokkaitouki (Hokkai Touki) AnlleLica QCut
i-1oba Kitagawa var, 5utt
iyaaae Frikino % KaratoukiAnge
lica 5tnensis (01iver) Di
els and Oninodake An11eLica gigas
Refers to the root of NakBi.
この発明に於いて当帰を使用する理由は、当帰は子宮の
機能を調節するとともに、不正子宮出血又は帯下に伴う
腹痛を和らげる鎮静、鎮痛効果を有するからである。The reason for using Toki in this invention is that it has a sedative and analgesic effect that not only regulates the function of the uterus, but also relieves abdominal pain associated with abnormal uterine bleeding or leucorrhoea.
更に、三七とは、ウコギ科Ara l 1aceaeサ
ンシチニンジ:/ PanaX nOtog!nsen
g (l1url(、) p、 )l C1H4n(P
anax ranchf HOO,Panax pse
udo−ginseng Wall。Furthermore, Sanshichi means Araliaceae: Araliaceae: / PanaX nOtog! nsen
g (l1url(,) p, )l C1H4n(P
anax ranchf HOO, Panax pse
Udo-ginseng Wall.
var、 notoginsentt (Burk、)
Hoo et Tseng) 、チキセツニンジンP
anax japonIcum C,A、 1d6y、
の根を指す。var, notoginsentt (Burk,)
Hoo et Tseng), Chikisetsu Carrot P
anax japonIcum C, A, 1d6y,
refers to the root of
この発明に於いて三七を使用する理由は、三七は消炎効
果を有するとともに血小板数を増加させることによる止
血効果をも有するからである。The reason why 37 is used in this invention is that 37 has an anti-inflammatory effect and also has a hemostatic effect by increasing the number of platelets.
尚、以上の紫根、当帰、三七には抗ウィルス、抗菌、抗
真菌作用がある為、化膿菌である連鎖球菌、ブドウ球菌
、リン菌、大腸菌、結核菌等による子宮内膵炎を治癒す
る効果も有する。In addition, the above-mentioned Shikon, Toki, and Sanshichi have antiviral, antibacterial, and antifungal effects, so they can cure intrauterine pancreatitis caused by pyogenic bacteria such as Streptococcus, Staphylococcus, Phosphorus, Escherichia coli, and Mycobacterium tuberculosis. It also has effects.
この発明に於いては、止血、鎮痛効果を更に増強すべく
、肉桂(クスノキ科LauraceaeニッケイC(n
naaomua 5ittboldri 146iSn
、(C1nnαao纜u蹴auct。In this invention, in order to further enhance hemostatic and analgesic effects, cinnamon (Lauraceae, Nikkei C) (n.
naaomua 5ittboldri 146iSn
, (C1nnαao-kauct.
Jap、 non Nees)の根皮)、白菊(ボタン
科Paeoni−aceaeシャクヤクPattoni
a LactifLora pill、の根の外皮を除
去したもの)、五味子(モクレン科Mognoliac
eae チョウセンゴミシSchizandraCh
ingnsis BHill、の成熟果実)、熟地黄(
ゴマノハグサ科5crophulariacaaeカイ
ケイジオウReh−mannia gLutinosa
1il)□S(h、1.hueichingensr
s(Chao et 5chih)Hsiaoの根茎)
、せんきゅう(セリ科Umbelliferaeせんき
ゆう LigusticumwaLLichii Fr
enCh、の根茎)、金砂(カイコガ科Bombyc
1dae 家蚕Bombyx履ori l、の糞)、
牡丹皮(ボタン科PaeoniaceaeボタンPag
onia 5uff−ruticosa And(、の
根皮)、前条(シソ科Labiataeケイガイ5ch
IzonOeta tenuifoHa 9riq、の
花穂をつけた茎枝或いは花穂)等を配合しても良い。Jap, non Nees), white chrysanthemum (Paeoni-aceae Pattoni)
a LactifLora pill, with the outer skin of the root removed), Schisandra (Mognoliacaceae)
eae SchizandraCh
ingnsis BHill, ripe fruits), ripe fruits of
Reh-mannia gLutinosa
1il)□S(h, 1.hueichingensr
s (Chao et 5chih) Hsiao rhizome)
, Umbelliferae LigusticumwaLLichii Fr.
enCh, rhizome), gold sand (Bombycidae Bombycidae)
1 dae Domestic silkworm Bombyx feces),
Paeoniaceae (Paeoniaceae Pag)
onia 5uff-ruticosa And (root bark), anterior row (Labiatae Labiatae 5ch
Stems, branches with flower spikes or flower spikes of Izon Oeta tenuifo Ha 9riq, etc. may be blended.
以上の紫根、当帰、三七等を使用して薬剤を調製するが
、配合量は症状に応じて適宜決定すれば良い。Drugs are prepared using the above-mentioned Shikon, Toki, Sanshichi, etc., and the amount to be added may be determined as appropriate depending on the symptoms.
薬剤の形態に関しては特に限定されないが、持続性を付
与すべくカカオ脂等の油脂性基剤、マクロゴール、グリ
セロゼラチン等の水溶性基剤、親水ワセリン等の親水性
基剤に紫根、当帰、三七を配合しても良い。The form of the drug is not particularly limited, but in order to provide sustainability, it may be prepared using an oily base such as cacao butter, a water-soluble base such as macrogol or glycerogelatin, or a hydrophilic base such as hydrophilic vaseline. , Sanshichi may be added.
尚、必要に応じてバラオキシ安息香酸メチル、パラオキ
シ安息香酸プロピル等の保存剤、安定剤等を配合しても
良い。Incidentally, if necessary, preservatives such as methyl paraoxybenzoate and propyl paraoxybenzoate, stabilizers, etc. may be added.
以上の如くして得られた薬剤をタンポンを構成するガー
ゼ、脱脂綿等に含浸させるか、或いはタンポンの外周面
に塗布することにより、この発明に係る不正子宮出血及
び帯下改善用タンポンを調製することができる。The tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention is prepared by impregnating gauze, absorbent cotton, etc. constituting the tampon with the drug obtained as described above, or by applying it to the outer circumferential surface of the tampon. be able to.
この発明に於いて使用されるタンポンは通常生理用品と
して使用されるタンポンであっても良く、消毒したガー
ゼ、脱脂綿等を高分子吸収体により被覆されたタンポン
が好適に使用される。The tampon used in this invention may be a tampon normally used as a sanitary product, and tampons made of sterilized gauze, absorbent cotton, etc. covered with a polymeric absorbent material are preferably used.
この発明に於いて前記薬剤は膣粘膜に容易に吸収される
ことが望ましく、前記薬剤をガーゼ、脱脂綿等に含浸さ
せた場合には、例えばタンポンの外層である高分子吸収
体を部分的に穿孔する等の手段を講ずれば良い。In this invention, it is desirable that the drug be easily absorbed into the vaginal mucosa, and when gauze, absorbent cotton, etc. are impregnated with the drug, for example, the polymer absorbent material that is the outer layer of a tampon may be partially perforated. All you have to do is take measures such as
以上の如くして得られた不正子宮出血及び帯下改善用タ
ンポンの使用に際しては、通常の生理用品のタンポンと
同様に使用すれば良い。The tampon for improving abnormal uterine bleeding and vaginal discharge obtained as described above may be used in the same manner as a normal sanitary product tampon.
以下、この発明に係る不正子宮出血及び帯下改善用タン
ポンの実施例及び試験例を示す。Examples and test examples of the tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention will be shown below.
(実施例)
ゴマ油1000g 、ミツロウ350g、豚腸25gを
約80℃で融解し混和した後、紫根(ムラサキの根を乾
燥したものの粉末)long 、当帰(トウキの根を乾
燥したものの粉末)90g、三七(サンシチニンジンの
根を乾燥したものの粉末)90gを添加して均等に混和
した。(Example) After melting and mixing 1000 g of sesame oil, 350 g of beeswax, and 25 g of pig intestine at about 80°C, add 90 g of Shikon (powder of dried purple root) and 90 g of toki (powder of dried root of Japanese trumpet). , 90 g of Sanshichi (powder of dried ginseng root) were added and mixed evenly.
これを熱時で布ごしした後、冷却して固化させ、軟膏剤
とした。This was rubbed through a cloth while hot, then cooled and solidified to form an ointment.
この軟膏剤をタンポン(商品名ニスリムタンバックスタ
ンポン、タンブランズ リミテッド社製)の外周面に塗
布して(塗布盟約3g)不正子宮出血及び帯下改善用タ
ンポンを調製した。This ointment was applied to the outer circumferential surface of a tampon (trade name: Nislim Tanvac Stampon, manufactured by Tambrands Limited) (approx. 3 g) to prepare a tampon for improving abnormal uterine bleeding and vaginal discharge.
(試験例1)
漿膜下筋腫をもつ20名の女性患者を対象として、実施
例で得られた不正子宮出血及び帯下改善用タンポンを3
日間使用(1日1回の使用で月経の間は除く)シた後の
症状の変化を調査した。(Test Example 1) 20 female patients with subserosal fibroids were given 3 tampons for improving abnormal uterine bleeding and leucorrhoea obtained in the example.
Changes in symptoms after daily use (once a day, excluding periods during menstruation) were investigated.
その結果、18名は不正子宮出血及び帯下の排出が確認
されず、更にこの18名を対象として子宮鏡による検査
を行なったところ9名については腫瘍の縮小及び消失が
確認された。As a result, no abnormal uterine bleeding or discharge of leucorrhea was confirmed in 18 patients, and when hysteroscopy was performed on these 18 patients, it was confirmed that the tumors had shrunk or disappeared in 9 patients.
(試験例2.)
膣炎をもつ30名の女性患者を対象として、実施例で得
られた不正子宮出血及び帯下改善用タンポンを2日間使
用(1日1回の使用で月経の間は除く)シた後の症状の
変化を調査した。(Test Example 2) Thirty female patients with vaginitis used the tampon for improving irregular uterine bleeding and leucorrhoea obtained in the example for two days (used once a day during menstruation). We investigated the changes in symptoms after the treatment.
その結果、30名全回に帯下の排出が確認されず、更に
この30名を対象として膣内8物の塗抹標本を作成して
固定、染色後検査したところ、23名については膣炎が
完治していることがわかった。As a result, discharge of leucorrhoea was not confirmed in all 30 patients, and when 8 vaginal smears were prepared, fixed, stained, and examined for these 30 patients, vaginitis was found in 23 patients. It turned out that he had fully recovered.
(発明の効果)
以上詳述した如くこの発明に係る不正子宮出血及び帯下
改善用タンポンは発紫根、当帰、三七を含有する薬剤が
含侵又は塗布されてなることを特徴とする不正子宮出血
及び帯下改善用タンポンであるから以下の効果を奏する
。(Effects of the Invention) As detailed above, the tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention is characterized by being impregnated with or coated with a drug containing Higen, Toki, and Sanshichi. Since it is a tampon for improving uterine bleeding and vaginal discharge, it has the following effects.
タンポンを構成する高分子吸収体、ガーゼ、脱脂綿等に
より帯下、血液等の分泌物を吸収するとともに、薬剤が
膣粘膜又は子宮内膜に直接或いは膣粘膜より吸収されて
間接的に作用して、腫瘍の縮小又は消失或いは炎症の回
復を行なうことにより不正子宮出血又は帯下を防止する
。The polymeric absorbent materials, gauze, absorbent cotton, etc. that make up the tampon absorb secretions such as discharge and blood, and the drug also acts directly on the vaginal mucosa or endometrium or indirectly by being absorbed from the vaginal mucosa. , prevent abnormal uterine bleeding or vaginal discharge by shrinking or eliminating tumors or recovering from inflammation.
また、この発明に係る不正子宮出血及び帯下改善用タン
ポンは、直接膣内に挿入して使用するから速効性及び持
続性を有し、薬剤の主成分が生薬である為副作用がない
。Furthermore, the tampon for improving abnormal uterine bleeding and leucorrhoea according to the present invention is fast-acting and long-lasting because it is inserted directly into the vagina, and has no side effects because the main component of the drug is a crude drug.
Claims (1)
されてなることを特徴とする不正子宮出血及び帯下改善
用タンポン。(1) A tampon for improving abnormal uterine bleeding and leucorrhoea, characterized by being impregnated with or coated with a drug containing Shikon, Toki, and Sanshichi.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1032478A JPH02212431A (en) | 1989-02-10 | 1989-02-10 | Tampon for improving metrorrhagia and leukorrhea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1032478A JPH02212431A (en) | 1989-02-10 | 1989-02-10 | Tampon for improving metrorrhagia and leukorrhea |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02212431A true JPH02212431A (en) | 1990-08-23 |
Family
ID=12360090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1032478A Pending JPH02212431A (en) | 1989-02-10 | 1989-02-10 | Tampon for improving metrorrhagia and leukorrhea |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02212431A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057264A1 (en) * | 2001-12-21 | 2003-07-17 | Kimberly-Clark Worldwide, Inc. | Feminine care products for the delivery of therapeutic substances |
-
1989
- 1989-02-10 JP JP1032478A patent/JPH02212431A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057264A1 (en) * | 2001-12-21 | 2003-07-17 | Kimberly-Clark Worldwide, Inc. | Feminine care products for the delivery of therapeutic substances |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6893648B2 (en) | Composition and method for treatment of vaginal dryness | |
CN103182070B (en) | External composition, and preparation and application thereof | |
CN104306324A (en) | Medical collagen gel and preparation method thereof | |
CN102526411B (en) | Chinese medicinal composition for treating surgical wound | |
CN102940854B (en) | Traditional Chinese medicine composition for facilitating wound healing after surgical operations, preparation process and application | |
CN110124099B (en) | Long-acting bacteriostatic compound periodontal plug treatment agent and preparation method thereof | |
CN102988555A (en) | Skin and tissue cream for burns | |
JPH02212431A (en) | Tampon for improving metrorrhagia and leukorrhea | |
CN103381196A (en) | Composition used for treating cervical erosion and application thereof | |
CN103191163B (en) | Skin wound repairing pharmaceutical composition | |
CN106236959A (en) | A kind of external-applied ointment treating hemorrhoid | |
CN107929549B (en) | Hemostatic and preparation method thereof | |
CN1969996A (en) | Chinese medicinal powder having functions in stopping bleeding, relieving pain, diminishing swelling and promoting granulation and preparation process thereof | |
CN116270828B (en) | Traditional Chinese medicine composition for wound healing and preparation method thereof | |
CN100336553C (en) | Externally applied medicine for treating uterine erosion and its preparing method | |
CN113209253B (en) | Traditional Chinese medicine composition for treating burn and scald wound surfaces, traditional Chinese medicine preparation and preparation method | |
CN117018158B (en) | Graphene acupoint plaster for warming uterus and relieving pain as well as preparation method and application thereof | |
CN115957277B (en) | Traditional Chinese medicine composition for treating HPV infection and cervical cancer precursor lesion as well as preparation and application thereof | |
CN109568476B (en) | Pharmaceutical composition for treating children chronic nasosinusitis and preparation method thereof | |
CN1209161C (en) | Medicine for external application for curing cervical erosion | |
CN106266152A (en) | A kind of pharmaceutical composition treating eczema and its production and use | |
CN1939469A (en) | Chinese medicinal plaster with analgetic, hemostatic, repercussive and sarcogenic functions | |
CN105213653A (en) | The traditional Chinese medicine emulsifiable paste of a kind of obstetrics prevention cesarean postoperate fat liquefaction of abdominal incision | |
WARRIAR et al. | Ayurvedic management of non-lactational breast abscess-Case Report | |
CN114558067A (en) | Gynecological hemostatic tissue regeneration promoting powder and application |